Correction to: GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data.

Andrei Carvalho SpositoOtávio BerwangerLuiz Sérgio F de CarvalhoJosé Francisco Kerr Saraiva

Published in: Cardiovascular diabetology (2019)

Following publication of the original article [1], based on the authors review, the GLP1 receptor agonists in type 2 diabetes published in Cardiovascular Diabetology, a meta-analysis of GLP-1 and non-GLP-1 based therapies was performed on cardiovascular outcomes.

Keyphrases

type diabetes
glycemic control
cardiovascular disease
insulin resistance
electronic health record
randomized controlled trial
systematic review
big data
adipose tissue
artificial intelligence
deep learning